Advances in external beam radiation for hepatocellular carcinoma, stereotactic body radiation therapy (SBRT) and particle therapy
Open Access
- 30 November 2024
- journal article
- Published by OAE Publishing Inc. in Hepatoma Research
- Vol. 10
Abstract
Hepatocellular carcinoma (HCC) represents a leading cause of cancer-related mortality globally. Due to frequently complex disease presentation and comorbid underlying cirrhosis, many patients are not ideal candidates for surgical resection, transplantation, or other local ablative treatments. External beam radiation therapy (EBRT) has emerged as a promising alternative. EBRT has gained prominence due to advancements in targeting and treatment delivery technology. Advanced modalities such as intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), stereotactic body radiation therapy (SBRT), and proton beam therapy (PBT) have dramatically improved the precision of radiation delivery, resulting in a far more favorable therapeutic ratio. Here we cover the evolution of current practice and future prospects of EBRT in treating HCC, emphasizing the enhanced efficacy and reduced toxicity provided by these advanced technologies, and improved integration with other loco-regional and systemic therapies in reviewing the current indications for treatment.Keywords
This publication has 49 references indexed in Scilit:
- Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinomaAnnals of Oncology, 2024
- Do We Have a Winner? Advocating for SBRT in HCC ManagementClinical and Translational Radiation Oncology, 2024
- Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trialCancer, 2023
- Therapeutic Outcome of Stereotactic Body Radiotherapy for Small Hepatocellular Carcinoma Lesions – A Systematic Review and Network Meta-analysisClinical Oncology, 2023
- Online verification of breath‐hold reproducibility using kV‐triggered imaging for liver stereotactic body radiation therapyJournal of Applied Clinical Medical Physics, 2023
- Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trialHepatology International, 2022
- Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With SorafenibJAMA Oncology, 2020
- Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity‐matched analysis of Surveillance, Epidemiology, and End Results databaseCancer Medicine, 2019
- Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular InvasionJAMA Oncology, 2018
- Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015